Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016
08/02/2021
/
Publications
/
IMPT
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
MRI-based IMPT planning for prostate cancer.
11/11/2019
/
Publications
/
IMPT
Published in the Green Journal, this study led by MGH aimed to quantify the clinical applicability of converted MR images as a substitute of CT for IMPT...
Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.
03/03/2019
/
Publications
/
VMAT
IMPT
A planning study conducted by a group of collective researchers in Europe. For six left sided breast cancer patients, treatment plans were made using non...
Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.
10/10/2020
/
Publications
/
Toxicity
IMPT
This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...
Proton Therapy in NSCLC
11/11/2018
/
Publications
/
IMPT
Immunotherapy
A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...
Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.
08/08/2018
/
Publications
/
IMPT
Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...
Advanced radiation techniques for locally advanced NSCLC: IMRT and proton therapy.
08/08/2018
/
Publications
/
IMPT
IMRT
This review article examined clinical outcomes data of IMRT and PBT for locally advanced NSCLC. This review pointed out that PBT is not considered the standard...
Reirradiation for locoregionally recurrent non-small cell lung cancer.
08/08/2018
/
Publications
/
Reirradiation
IMPT
Survival
In the context of definitive retreatment, increasing reRT dose can potentially improve OS and offer a chance of cure, particularly in patients with limited loco...
Proton therapy for locally advanced breast cancer: A systematic review of the literature.
11/11/2017
/
Publications
/
IMPT
This systematic review reported that protons offered a better target coverage than photons, even compared with intensity modulation radiation therapy (including...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.